跳到正文
openFDA 已分级药品召回执法报告·· 12 天前精选AI 评分69

FDA 执法报告 D-0173-2027 将 American Health Packaging 氰钴胺注射液 24394A 批次列为二级召回

FDA drug enforcement D-0173-2027: American Health Packaging — Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.

AI 导读

FDA 召回执法报告 D-0173-2027 将 American Health Packaging 的氰钴胺注射液 1,000 mcg/mL 批次 24394A 列为二级召回,原因为潜在玻璃颗粒污染。该召回由企业自愿发起,发起日期为 2026 年 10 月 22 日,涉及 4,097 箱、全美分销。报告日期为 2026 年 11 月 11 日,状态 Ongoing 不代表实时召回进展。

推荐理由

记录载明该注射剂批次因潜在玻璃颗粒污染被列为二级召回,并给出批号与全美分销范围,便于核对召回边界。

正文 · AI 翻译

FDA 药品召回执法报告 — D-0173-2027

报告发布日期:2026-11-11。这是执法报告日期,不是召回启动日期。

范围:一条已分类的药品召回记录;event_id 可能归组多个产品。无召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。

openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。

完整官方产品记录(包括 openFDA 统一标识符):

{

"address_1": "2550 John Glenn Ave Ste A",

"address_2": "",

"center_classification_date": "20261105",

"city": "Columbus",

"classification": "Class II",

"code_info": "Lot: 24394A, Exp 10-31-2026",

"country": "United States",

"distribution_pattern": "Nationwide in the USA",

"event_id": "100204",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {},

"postal_code": "43217-1188",

"product_description": "Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint Laboratories. Carton NDC 68001-542-60; Vial NDC 68001-542-59",

"product_quantity": "4,097- cartons (25 x 1mL vials)",

"product_type": "Drugs",

"reason_for_recall": "Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.",

"recall_initiation_date": "20261022",

"recall_number": "D-0173-2027",

"recalling_firm": "American Health Packaging",

"report_date": "20261111",

"state": "OH",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov